aspirin has been researched along with Menopause in 11 studies
Aspirin: The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5)
acetylsalicylate : A benzoate that is the conjugate base of acetylsalicylic acid, arising from deprotonation of the carboxy group.
acetylsalicylic acid : A member of the class of benzoic acids that is salicylic acid in which the hydrogen that is attached to the phenolic hydroxy group has been replaced by an acetoxy group. A non-steroidal anti-inflammatory drug with cyclooxygenase inhibitor activity.
Menopause: The last menstrual period. Permanent cessation of menses (MENSTRUATION) is usually defined after 6 to 12 months of AMENORRHEA in a woman over 45 years of age. In the United States, menopause generally occurs in women between 48 and 55 years of age.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To assess a novel hormone replacement therapy (HRT) paradigm using raloxifene, aspirin combined with estrogen in rabbit model of menopause." | 7.77 | Combination of raloxifene, aspirin and estrogen as novel paradigm of hormone replacement therapy in rabbit model of menopause. ( He, H; Hu, KQ; Hu, Q; Li, JF; Liu, ZM; Wang, X; Yang, FL, 2011) |
| "To assess a novel hormone replacement therapy (HRT) paradigm using raloxifene, aspirin combined with estrogen in rabbit model of menopause." | 3.77 | Combination of raloxifene, aspirin and estrogen as novel paradigm of hormone replacement therapy in rabbit model of menopause. ( He, H; Hu, KQ; Hu, Q; Li, JF; Liu, ZM; Wang, X; Yang, FL, 2011) |
| "Oesophageal adenocarcinoma is characterised by a strong male predominance." | 1.72 | Menopausal hormone therapy and risk of oesophageal adenocarcinoma in a population-based cohort study. ( Lagergren, J; Santoni, G; Xie, SH, 2022) |
| "The study group consisted of 92 postmenopausal women: 1) group G1 (n=30), treated with transdermal HT (17β-estradiol 50 μg/day plus NETA 170 μg/day); 2) group G2 (n=31), treated with the above transdermal HT and low dosage of acetylsalicylic acid (ASA); 3) control group P (n=31)." | 1.42 | Effect of transdermal hormone therapy on platelet haemostasis in menopausal women. ( Pertyńska-Marczewska, M; Pertyński, T; Stachowiak, G, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (45.45) | 18.7374 |
| 1990's | 1 (9.09) | 18.2507 |
| 2000's | 2 (18.18) | 29.6817 |
| 2010's | 2 (18.18) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Xie, SH | 1 |
| Santoni, G | 1 |
| Lagergren, J | 1 |
| Stachowiak, G | 1 |
| Pertyński, T | 1 |
| Pertyńska-Marczewska, M | 1 |
| Yang, FL | 1 |
| Hu, KQ | 1 |
| Wang, X | 1 |
| Liu, ZM | 1 |
| Hu, Q | 1 |
| Li, JF | 1 |
| He, H | 1 |
| Easter, MJ | 1 |
| Marshall, JM | 1 |
| Dores, GM | 1 |
| Miller, ME | 1 |
| Thorpe, SL | 1 |
| Slattery, ML | 1 |
| Benson, J | 1 |
| Ma, KN | 1 |
| Schaffer, D | 1 |
| Potter, JD | 1 |
| Nordøy, A | 1 |
| Svensson, B | 1 |
| Haycraft, D | 1 |
| Hoak, JC | 1 |
| Wiebe, D | 1 |
| Spranger, M | 1 |
| Aspey, BS | 1 |
| Harrison, MJ | 1 |
| Sheffer, AL | 1 |
| Kolendorf, K | 1 |
| Siersbaek-Nielsen, K | 1 |
| Hansen, MJ | 1 |
| Friis, T | 1 |
| Klittscher, K | 1 |
1 review available for aspirin and Menopause
| Article | Year |
|---|---|
Drug treatment of urticaria and angioedema.
Topics: Angioedema; Aspirin; Cold Temperature; Diet Therapy; Female; Histamine H1 Antagonists; Histamine Rel | 1973 |
10 other studies available for aspirin and Menopause
| Article | Year |
|---|---|
Menopausal hormone therapy and risk of oesophageal adenocarcinoma in a population-based cohort study.
Topics: Adenocarcinoma; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cohort Studies; Esophageal Neoplas | 2022 |
Effect of transdermal hormone therapy on platelet haemostasis in menopausal women.
Topics: Administration, Cutaneous; Aspirin; Blood Platelets; Estradiol; Estrogen Replacement Therapy; Female | 2015 |
Combination of raloxifene, aspirin and estrogen as novel paradigm of hormone replacement therapy in rabbit model of menopause.
Topics: Animals; Aspirin; Drug Therapy, Combination; Estrogens; Female; Hormone Replacement Therapy; Menopau | 2011 |
Contribution of prostanoids to endothelium-dependent vasodilatation in the digital circulation of women with primary Raynaud's disease.
Topics: Acetylcholine; Adult; Aging; Analysis of Variance; Aspirin; Case-Control Studies; Cyclooxygenase Inh | 2005 |
Platelet adhesion at low shear rate: study of a normal population.
Topics: Adult; Aspirin; Collagen; Contraceptives, Oral; Female; Fibronectins; Humans; Male; Menopause; Menst | 1993 |
Trans-fatty acids and colon cancer.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Colonic Neoplasms; Diet Records; Dietary Fat | 2001 |
The influence of age, sex, and the use of oral contraceptives on the inhibitory effects of endothelial cells and PGI2 (prostacyclin) on platelet function.
Topics: Adenosine Diphosphate; Adult; Age Factors; Aged; Aspirin; Blood Cell Count; Blood Platelets; Cells, | 1978 |
Sex difference in antithrombotic effect of aspirin.
Topics: Adult; Aged; Aspirin; Female; Humans; Male; Menopause; Middle Aged; Orchiectomy; Osmolar Concentrati | 1989 |
Evaluation of thyroid status with "effective thyroxine ratio" (E.T.R.).
Topics: Adolescent; Adult; Aged; Aspirin; Depression, Chemical; Estrogens; Evaluation Studies as Topic; Fema | 1974 |
[Control of pain with target therapy with "Spasmo-Dolviran"].
Topics: Analgesics; Aspirin; Codeine; Female; Headache; Humans; Menopause; Neuralgia; Pain; Phenacetin; Phen | 1967 |